Your Health Plan:
Your Health Plan:
Not SelectedEPCLUSA (sofosbuvir and velpatasvir) is a brand-name prescription drug for treatment of Cirrhosis. EPCLUSA is a combination of hepatitis c virus ns5a inhibitor and hepatitis c virus nucleotide analog ns5b polymerase inhibitor. It is available in the form of oral tablet / oral pellet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $9600-28200.
Patient Assistance Prorgams and Coupons are found:
Other alternatives to EPCLUSA may include:
